NCT05973032View on ClinicalTrials.gov

MRD Detection by NGS in Pediatric B-ALL

CompletedOBSERVATIONAL
Enrollment

430

Participants

Timeline

Start Date

November 1, 2018

Primary Completion Date

August 31, 2022

Study Completion Date

August 31, 2022

Conditions
Acute Lymphoblastic Leukemia, Pediatric
Interventions
OTHER

MRD

Calculate the 3-year EFS based on the MRD status (MRD positive and negative groups)

Trial Locations (1)

310003

The Children's Hospital of Zhejiang University School of Medicine, Hangzhou

All Listed Sponsors
lead

The Children's Hospital of Zhejiang University School of Medicine

OTHER

NCT05973032 - MRD Detection by NGS in Pediatric B-ALL | Biotech Hunter | Biotech Hunter